{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:23:50Z","timestamp":1770510230493,"version":"3.49.0"},"reference-count":20,"publisher":"Japanese Society of Veterinary Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Veterinary Medical Science","J. Vet. Med. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1292\/jvms.18-0011","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T17:09:11Z","timestamp":1517245751000},"page":"499-502","source":"Crossref","is-referenced-by-count":7,"title":["Phosphodiesterase 9 (PDE9) regulates bovine tracheal smooth muscle relaxation"],"prefix":"10.1292","volume":"80","author":[{"given":"Tsuyoshi","family":"TAJIMA","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Nippon Veterinary and Life Science University, 1-7-1 Kyounan-cho, Musashino-shi, Tokyo 180-8602, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"SHINODA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Nippon Veterinary and Life Science University, 1-7-1 Kyounan-cho, Musashino-shi, Tokyo 180-8602, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimoto","family":"URAKAWA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Nippon Veterinary and Life Science University, 1-7-1 Kyounan-cho, Musashino-shi, Tokyo 180-8602, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"SHIMIZU","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Nippon Veterinary and Life Science University, 1-7-1 Kyounan-cho, Musashino-shi, Tokyo 180-8602, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"KANEDA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Nippon Veterinary and Life Science University, 1-7-1 Kyounan-cho, Musashino-shi, Tokyo 180-8602, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barnes, P. J. 2013. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. <i>J. Allergy Clin. Immunol.<\/i> 131: 636\u2013645.","DOI":"10.1016\/j.jaci.2012.12.1564"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Beavo, J. A. 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. <i>Physiol. Rev.<\/i> 75: 725\u2013748.","DOI":"10.1152\/physrev.1995.75.4.725"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bloom, T. J. 2002. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle. <i>Can. J. Physiol. Pharmacol.<\/i> 80: 1132\u20131135.","DOI":"10.1139\/y02-149"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Conti, M., Nemoz, G., Sette, C. and Vicini, E. 1995. Recent progress in understanding the hormonal regulation of phosphodiesterases. <i>Endocr. Rev.<\/i> 16: 370\u2013389.","DOI":"10.1210\/edrv-16-3-370"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. da Silva, F. H., Pereira, M. N., Franco-Penteado, C. F., De Nucci, G., Antunes, E. and Claudino, M. A. 2013. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice. <i>Int. J. Impot. Res.<\/i> 25: 69\u201373.","DOI":"10.1038\/ijir.2012.35"},{"key":"6","unstructured":"6. Diederen, R. M., La Heij, E. C., Markerink-van Ittersum, M., Kijlstra, A., Hendrikse, F. and de Vente, J. 2007. Selective blockade of phosphodiesterase types 2, 5 and 9 results in cyclic 3\u20185\u2019 guanosine monophosphate accumulation in retinal pigment epithelium cells. <i>Br. J. Ophthalmol.<\/i> 91: 379\u2013384."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fawcett, L., Baxendale, R., Stacey, P., McGrouther, C., Harrow, I., Soderling, S., Hetman, J., Beavo, J. A. and Phillips, S. C. 2000. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i> 97: 3702\u20133707.","DOI":"10.1073\/pnas.97.7.3702"},{"key":"8","unstructured":"8. Fisher, D. A., Smith, J. F., Pillar, J. S., St Denis, S. H. and Cheng, J. B. 1998. Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. <i>J. Biol. Chem.<\/i> 273: 15559\u201315564."},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Kaneda, T., Fujieda, T., Eto, Y., Nagai, Y., Sasaki, N., Tajima, T., Urakawa, N. and Shimizu, K. 2012. Key role of glycogen storage in high K+-induced contraction of the smooth muscles of the bovine trachea. <i>J. Vet. Med. Sci.<\/i> 74: 1277\u20131282.","DOI":"10.1292\/jvms.12-0020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J. and Manganiello, V. C. 2014. Advances in targeting cyclic nucleotide phosphodiesterases. <i>Nat. Rev. Drug Discov.<\/i> 13: 290\u2013314.","DOI":"10.1038\/nrd4228"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Nagasaki, S., Nakano, Y., Masuda, M., Ono, K., Miki, Y., Shibahara, Y. and Sasano, H. 2012. Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study. <i>BJU Int.<\/i> 109: 934\u2013940.","DOI":"10.1111\/j.1464-410X.2011.10429.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Schudt, C., Hatzelmann, A., Beume, R. and Tenor, H. 2011. Phosphodiesterase inhibitors: history of pharmacology. <i>Handb. Exp. Pharmacol.<\/i> 2011: 1\u201346.","DOI":"10.1007\/978-3-642-17969-3_1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Smith, S. J., Brookes-Fazakerley, S., Donnelly, L. E., Barnes, P. J., Barnette, M. S. and Giembycz, M. A. 2003. Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i> 284: L279\u2013L289.","DOI":"10.1152\/ajplung.00170.2002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Stuart-Smith, K., Bynoe, T. C., Lindeman, K. S. and Hirshman, C. A. 1994. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro. <i>J. Appl. Physiol.<\/i> 77: 1142\u20131147.","DOI":"10.1152\/jappl.1994.77.3.1142"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Su, T., Zhang, T., Xie, S., Yan, J., Wu, Y., Li, X., Huang, L. and Luo, H. B. 2016. Discovery of novel PDE9 inhibitors capable of inhibiting A\u03b2 aggregation as potential candidates for the treatment of Alzheimer\u2019s disease. <i>Sci. Rep.<\/i> 6: 21826.","DOI":"10.1038\/srep21826"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Torphy, T. J. 1998. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. <i>Am. J. Respir. Crit. Care Med.<\/i> 157: 351\u2013370.","DOI":"10.1164\/ajrccm.157.2.9708012"},{"key":"17","unstructured":"18. Toward, T. J., Smith, N. and Broadley, K. J. 2004. Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease. <i>Am. J. Respir. Crit. Care Med.<\/i> 169: 227\u2013234."},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. van Staveren, W. C., Glick, J., Markerink-van Ittersum, M., Shimizu, M., Beavo, J. A., Steinbusch, H. W. and de Vente, J. 2002. Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain. <i>J. Neurocytol.<\/i> 31: 729\u2013741.","DOI":"10.1023\/A:1025704031210"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Wang, H., Luo, X., Ye, M., Hou, J., Robinson, H. and Ke, H. 2010. Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis. <i>J. Med. Chem.<\/i> 53: 1726\u20131731.","DOI":"10.1021\/jm901519f"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Yu, Y. F., Huang, Y. D., Zhang, C., Wu, X. N., Zhou, Q., Wu, D., Wu, Y. and Luo, H. B. 2017. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer\u2019s Disease. <i>ACS Chem. Neurosci.<\/i> 8: 2522\u20132534.","DOI":"10.1021\/acschemneuro.7b00268"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/80\/3\/80_18-0011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:08:44Z","timestamp":1570648124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/80\/3\/80_18-0011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.18-0011","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}